- Turkish Journal of Internal Medicine
- Vol: 4 - Supplement 1 Special Issue
- Evaluation of Patients Performed with Saline Infusion Test with a Pre-Diagnosis of Primary Hyperaldo...
Evaluation of Patients Performed with Saline Infusion Test with a Pre-Diagnosis of Primary Hyperaldosteronism
Authors : Coşkun Ateş, Gül Ada, Filiz Mercan Saridaş, Ensar Aydemir, Erhan Hocaoğlu, Özen Öz Gül, Soner Cander, Canan Ersoy, Erdinç Ertürk
Pages : 29-33
Doi:10.46310/tjim.1072050
View : 20 | Download : 4
Publication Date : 2022-04-01
Article Type : Research
Abstract :Background: Primary hyperaldosteronism (PHA) is a primarily treatable cause of arterial hypertension characterized by low plasma renin and high aldosterone levels. The prevalence of secondary hypertension as a common endocrine cause is 5-13%. The plasma aldosterone/renin ratio (ARR) is the best available method for PHA screening. One or more confirmatory tests may be required to confirm or exclude patients' diagnoses. One frequently used confirmatory test is the saline infusion test (SİT). We aimed to screen the patients who underwent SİT with the preliminary diagnosis of PHA and to compare the results of the patients diagnosed with essential hypertension (EH) and PHA. Material and Methods: Seventy-seven patients with a history of drug-resistant hypertension or unexplained spontaneous or diuretic-induced hypokalemia or adrenal incidentaloma, or a family history of early-onset hypertension or cerebrovascular accident at a young age ( 0.05). Basal plasma aldosterone (p 0.05). The mean sodium value was significantly higher than the IHA (p <0.05). Conclusion: Our study determined that the saline infusion test could be used to confirm the diagnosis of primary hyperaldosteronism. Its use alone was not sufficient in the differential diagnosis of aldosterone-synthesizing adenoma and idiopathic hyperaldosteronism.Keywords : primary hyperaldosteronism, saline infusion test, essential hypertension, secondary hypertension, endocrine hypertension